+2,684.0%
SNDK vs CVS
+35.9%
+2,648.1%
-56.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | CVS | Excess | Alpha |
|---|---|---|---|---|
| 1D | +11.9% | -0.5% | +12.4% | +12.1% |
| 7D | +17.2% | +4.0% | +13.2% | +15.5% |
| 30D | +28.8% | -2.4% | +31.2% | +29.9% |
| 3M | -1.1% | +2.7% | -3.8% | -1.8% |
| 6M | +190.5% | +21.9% | +168.6% | +169.0% |
| YTD | +633.0% | +24.7% | +608.3% | +546.3% |
| 1Y | +2,684.0% | +35.4% | +2,648.6% | +2,258.6% |
| All | +2,684.0% | +35.9% | +2,648.1% | +2,258.6% |
Cumulative growth
Daily Returns
Daily percentage return beside CVS.
Daily Out/Under-Performance
Portfolio return minus CVS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CVS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded CVS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling